Bromide

Bromide

SCHEMBL22407698

Br.CN(C)CC=O

nearest known ligand 0.00

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ACHEADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB1ADRB2ADRB3APH1AAPH1BCHRM2CHRM3EZH2GRIN2AHTR1AHTR1BHTR1DHTR1FHTR3ANCSTNP2RY12PSEN1PSEN2PSENENSIGMAR1SLC6A2SLC6A3SLC6A4

The experimentally established mechanism targets of Bromide. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL200206 0.96
Iodide SCHEMBL29042352 0.93
SCHEMBL811660 0.93
Hydrochloric Acid SCHEMBL127053 0.93
SCHEMBL767933 0.93
Hydrochloric Acid SCHEMBL6637499 0.93
SCHEMBL2351930 0.93
SCHEMBL10748747 0.93
Hydrochloric Acid SCHEMBL30594918 0.93
SCHEMBL7912373 0.93

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 17 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-118317944-A Acyclic lipids and methods of use thereof 雷纳嘉德医疗管理公司 2024-07-09 CN disclosed
CN-118234707-A Cyclic lipids and methods of use thereof 雷纳嘉德医疗管理公司 2024-06-21 CN disclosed
CN-117105811-A Membrane Fusion Compounds for Delivery of Bioactive Molecules 日东电工株式会社 2023-11-24 CN disclosed
CN-113943228-B Alkaloid pulmonin B derivative, synthesis thereof and application thereof in preventing and treating plant virus and germ diseases 天津师范大学 2023-10-27 CN disclosed
CN-111386105-B Membrane Fusion Compounds for Delivery of Bioactive Molecules 日东电工株式会社 2023-09-15 CN disclosed
US-20230192613-A1 Charged Ion Channel Blockers and Methods for Use NOCION THERAPEUTICS INC (US) 2023-06-22 US disclosed
US-11603355-B2 Charged ion channel blockers and methods for use Nocion Therapeutics, Inc. (US) 2023-03-14 US disclosed
CN-115768351-A Fluid characterization method 新生代吉恩公司 2023-03-07 CN disclosed
CN-115066207-A Method and system for menses group analysis 新生代吉恩公司 2022-09-16 CN disclosed
EP-3938345-A1 CHARGED ION CHANNEL BLOCKERS AND METHODS FOR USE Nocion Therapeutics, Inc. (US) 2022-01-19 EP disclosed
US-10968179-B2 Charged ion channel blockers and methods for use Nocion Therapeutics, Inc. (US) 2021-04-06 US disclosed
US-20210061763-A1 CHARGED ION CHANNEL BLOCKERS AND METHODS FOR USE NOCION THERAPEUTICS INC (US) 2021-03-04 US disclosed
CN-107082747-B Compounds for targeted drug delivery and enhancing siRNA activity 日东电工株式会社 2020-11-20 CN disclosed
US-20200290953-A1 Charged Ion Channel Blockers and Methods for Use Nocion Therapeutics, Inc. 2020-09-17 US disclosed
WO-2020185830-A1 CHARGED ION CHANNEL BLOCKERS AND METHODS FOR USE Nocion Therapeutics, Inc. (US) 2020-09-17 WO disclosed
CN-111386105-A Membrane fusion compounds for delivery of bioactive molecules 日东电工株式会社 2020-07-07 CN disclosed
CN-107043334-B Compounds for targeted drug delivery and enhancing siRNA activity 日东电工株式会社 2020-06-16 CN disclosed